Innovation Fuels Growth In GI Endoscopy

Advances in imaging and interventional endoscopy are improving cancer detection and enabling less invasive approaches to diagnose and treat disorders in the gastrointestinal tract. These emerging procedures are poised to fuel growth in the $7 billion global market for GI endoscopy.

Technological advances in imaging and interventional endoscopy are paving the way for new and improved approaches to diagnosing and treating gastrointestinal (GI) disorders. At this year’s Digestive Disease Week (DDW) meeting, held in Chicago in May, researchers and manufacturers were showcasing new endoscopes, tools, and imaging technologies designed to improve diagnostic performance, clinical workflow, and safety during GI endoscopy. These technologies are helping to improve cancer detection and are allowing gastroenterologists to use less invasive approaches to procedures that have typically been performed using surgical or percutaneous techniques. These emerging procedures are poised to fuel growth in the global market for GI endoscopy, which is currently valued at $7 billion, according to EndoChoice Holdings Inc., a competitor in this space.

Colonoscopy is widely accepted as the gold standard for detecting colorectal cancer and precancerous polyps known as adenomas. However, physicians...

More from Europe

UK’s Dementia Trials Accelerator Works To Fast-Track Trial Recruitment

 

A government-backed program is working on improving the ability to run dementia clinical trials in the UK, and access to trials for participants.

Inaccurate Carbon Dioxide Readings Prompt Class I Recall Of Draeger Ventilation Filters

 

Draeger Medical has recalled certain SafeStar and TwinStar ventilation filters after reports of serious injuries caused by misleading carbon dioxide readings.

UK MHRA Ready To Evolve Approach To In-House Manufactured Medtech

 
• By 

The UK device regulator wants to align health institution device exemptions with its evolving policy of agile regulation of medtech in the British market. It asks stakeholders to complete a survey by Sept. 15.

FDA Changes Fail To Diminish US Appeal To European Medtech Industry

 

Despite staffing cuts and uncertainty at the FDA, the US still offers EU medtech firms stronger regulatory support, regulatory expert Bassil Akra told Medtech Insight. This is especially valued as EU rules are often viewed as overly stringent, unclear and difficult to follow.

More from Geography

Inaccurate Carbon Dioxide Readings Prompt Class I Recall Of Draeger Ventilation Filters

 

Draeger Medical has recalled certain SafeStar and TwinStar ventilation filters after reports of serious injuries caused by misleading carbon dioxide readings.

UK MHRA Ready To Evolve Approach To In-House Manufactured Medtech

 
• By 

The UK device regulator wants to align health institution device exemptions with its evolving policy of agile regulation of medtech in the British market. It asks stakeholders to complete a survey by Sept. 15.

FDA Panel Supports Dermal Fillers For Décolletage Use

 
• By 

An FDA panel has endorsed the use of dermal fillers for décolletage, but warned of patient safety concerns. The filler can cause complications with future imaging and pregnancy or breastfeeding, panelists said. Regulatory measures and patient studies are recommended for better outcomes.